Medtech Accelerator Announces 61 Startups for its 2023 Cohort
June 09, 2023
June 09, 2023
We are thrilled to share that we have made it into the prestigious MedTech Innovator 2023 Cohort, comprising of only the top #medtech and #healthtech startups! With a rigorous acceptance rate of just 5%, we are honored to be recognized among the best in the industry.
Our latest
news and publications
news and publications
-
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026 -
Read
Sentante Accelerates Remote Stroke Surgery Innovation With First Live TrialsDecember 12, 2025 -
Read
Critical Stroke Procedure Performed from Across the AtlanticNovember 11, 2025